Serum kinetics, distribution and excretion of silver in rabbits following 28 days after a single intravenous injection of silver nanoparticles

Nanotoxicology

Volumn 7, Issue 6, 2012, Pages 1120-1130

  Lee, Yeonjin ^a   Kim, Pilje ^b   Yoon, Junheon ^b   Lee, Byoungcheun ^b   Choi, Kyunghee ^b   Kil, Ki Hyun ^c   Park, Kwangsik ^a  

^a Dongduk Women's University   (South Korea)

^b National Institute of Environmental Research   (South Korea)

^c Chemon Inc   (South Korea)

Author keywords

Distribution; Excretion; Kinetics; Rabbits; Silver nanoparticles

Indexed keywords

SILVER NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARGYRIA; ARTICLE; BILIARY EXCRETION; CONTROLLED STUDY; FECES ANALYSIS; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; LIVER; LUNG; MINERAL BLOOD LEVEL; NONHUMAN; PHARMACOKINETICS; PRIORITY JOURNAL; RABBIT; TESTIS; THYMUS; TISSUE DISTRIBUTION; URINALYSIS;

ORYCTOLAGUS CUNICULUS;

EID: 84881286938     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.3109/17435390.2012.710660     Document Type: Article

References (32)

1. Ahamed M, Karns M, Goodson M, Rowe J, Hussain SM, Schlager JJ, et al. 2008. DNA damage response to different surface chemistry of silver nanoparticles in mammalian cell. Toxicol Appl Pharmacol 233(3):404-410
2. Arora S, Jain J, Rajwade JM, Paknikar KM. 2009. Interactions of silver nanoparticles with primary mouse fibroblasts and liver cells. Toxicol Appl Pharmacol 236(3):310-318
3. AshaRani PV, Low KahMun G, Hande MP, Valiyaveettil S. 2009. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 3(2):279-290
4. Braydich-Stolle L, Hussain S, Schlager JJ, Hofmann MC. 2005. In vitro cytotoxicity of nanoparticles in mammalian germ line stem cells. Toxicol Sci 88(2):412-419
5. Carlson C, Hussain SM, Schrand AM, Braydich-Stolle LK, Hess KL, Jones RL, et al. 2008. Unique cellular interaction of silver nanoparticles: Size-dependent generation of reactive oxygen species. J Phys Chem B 112(43):13608-13619
6. Chen X, Schluesener HJ. 2008. Nanosilver: A nanoproduct in medical application. Toxicol Lett 176(1):1-12
7. Chen YA, Hsu KY. 2009. Pharmacokinetics of (-)-epicatechin in rabbits. Arch Pharm Res 32(1):149-154
8. Farkas J, Christian P, Gallego-Urrea JA, Roos N, Hassellöv M, Tollefsen KE, et al. 2011. Uptake and effects of manufactured silver nanoparticles in rainbow trout (Oncorhynchus mykiss) gill cells. Aquat Toxicol 101(1):117-125
9. Granero GE, Amidon GL. 2008. Possibility of enterohepatic recycling of ketoprofen in dogs. Int J Pharm 349(1-2):166-171
10. Hsin YH, Chen CF, Huang S, Shih TS, Lai PS, Chueh PJ. 2008. The apoptotic effect of nanosilver is mediated by a ROS-And JNKdependent mechanism involving the mitochondrial pathway in NIH3T3 cells. Toxicol Lett 179(3):130-139
11. Jain J, Arora S, Rajwade JM, Omray P, Khandelwal S, Paknikar KM. 2009. Silver nanoparticles in therapeutics: Development of an antimicrobial gel formulation for topical use. Mol Pharm 6(5):1388-1401
12. Kim WY, Kim J, Park JD, Ryu HY, Yu IJ. 2009. Histological study of gender differences in accumulation of silver nanoparticles in kidneys of fischer 344 rats. J Toxicol Environ Health A 72(21-22):1279-1284
13. Kim YS, Kim JS, Cho HS, Rha DS, Kim JM, Park JD, et al. 2008. Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in sprague-dawley rats. Inhal Toxicol 20(6):575-583
14. Lankveld DP, Oomen AG, Krystek P, Neigh A, Troost-de Jong A, Noorlander CW, et al. 2010. The kinetics of the tissue distribution of silver nanoparticles of different sizes. Biomaterials 31(32):8350-8361
15. 2 and silver. Inhal Toxicol 23(4):226-236
16. Lem KW, Choudhury A, Lakhani AA, Kuyate P, Haw JR, Lee DS, et al. 2012. Use of nanosilver in consumer products. Recent Pat Nanotechnol (6):60-72
17. Limbach LK, Wich P, Manser P, Grass RN, Bruinink A, Stark WJ. 2007. Exposure of engineered nanoparticles to human lung epithelial cells: Influence of chemical composition and catalytic activity on oxidative stress. Environ Sci Technol 41(11):4158-4163
18. Loeschner K, Hadrup N, Qvortrup K, Larsen A, Gao X, Vogel U, et al. 2011. Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate. Fibre Toxicol 8:18
19. Lubick N. 2008. Nanosilver toxicity: Ions, nanoparticles or both?. Environ Sci Technol 42(23):8617
20. Park EJ, Yi J, Kim Y, Choi K, Park K. 2010. Silver nanoparticles induce cytotoxicity by a Trojan-horse type mechanism. Toxicol In Vitro 24(3):872-878
21. Park K, Park EJ, Chun I, Choi K, Lee SH, Yoon J, et al. 2011. Bioavailability and toxicokinetics of citrate-coated silver nanoparticles in rats. Arch Pharm Res 34(1):153-158
22. Quadros ME, Marr LC. 2011. Silver nanoparticles and total aerosols emitted by nanotechnology-related consumer spray products. Environ Sci Technol 45(24):10713-10719
23. Quadros ME, Marr LC. 2010. Environmental and human health risks of aerosolized silver nanoparticles. J Air Waste Manag Assoc 60 (7):770-781
24. Roberts MS, Magnusson BM, Burczynski FJ, Weiss M. 2001. Enterohepatic circulation: Physiological, pharmacokinetic and clinical implications. Clin Pharmaco Kinet 41(10):751-790
25. Sharma HS, Hussain S, Schlager J, Ali SF, Sharma A. 2010. Influence of nanoparticles on blood-brain barrier permeability and brain edema formation in rats. Acta Neurochir Suppl 106:359-364
26. Stebounova LV, Adamcakova-Dodd A, Kim JS, Park H, O'Shaughnessy PT, Grassian VH, et al. 2011. Nanosilver induces minimal lung toxicity or inflammation in a subacute murine inhalation model. Part Fibre Toxicol 8(1):5
27. Sun YN, Wang CD, Zhang XM, Ren L, Tian XH. 2011. Shape dependence of gold nanoparticles on in vivo acute toxicological effects and biodistribution. J Nanosci Nanotechnol 11(2):1210-1216
28. Sung JH, Ji JH, Park JD, Yoon JU, Kim DS, Jeon KS, et al. 2009. Subchronic inhalation toxicity of silver nanoparticles. Toxicol Sci 108(2):452-461
29. Tang J, Xiong L, Wang S, Wang J, Liu L, Li J, et al. 2009. Distribution, translocation and accumulation of silver nanoparticles in rats. J Nanosci Nanotechnol 9(8):4924-4932
30. Tang J, Xi T. 2008. Status of biological evaluation on silver nanoparticles. Sheng Wu Yi Xue Gong Cheng Xue ZaZhi 25(4):958-961
31. Tang J, Xiong L, Zhou G, Wang S, Wang J, Liu L, et al. 2010. Silver nanoparticles crossing through and distribution in the blood-brain barrier in vitro. J Nanosci Nanotechnol 10(10): 6313-6317
32. Thrall L. 2007. A nano Trojan horse. Environ Sci Technol 41(11): 3791-3792